New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination

Joshua Kaminetsky; Donald Rudikoff

doi:10.1002/ccr3.4865

New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination

Clin Case Rep. 2021 Sep 26;9(9):e04865. doi: 10.1002/ccr3.4865. eCollection 2021 Sep.

Authors

Joshua Kaminetsky¹, Donald Rudikoff²

Affiliations

¹ Department of Dermatology Icahn School of Medicine at Mount Sinai New York New York USA.
² Department of Dermatology BronxCare Health System Bronx New York USA.

Abstract

The COVID-19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well-tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients.

Keywords: COVID‐19; adverse reaction; mRNA vaccine; vitiligo.

Publication types

Case Reports